[1]
“Efficacy of Empagliflozin versus Dapagliflozin in Heart Failure with Preserved Ejection Fraction: A Randomized Controlled Trial”, Glob. J. Med. Pharm. Sci., vol. 1, no. 3, pp. 09–16, Oct. 2023, Accessed: Jun. 25, 2026. [Online]. Available: http://www.globapc.com/index.php/gjmps/article/view/28